Latest GLSI reports update at 2024-04-15: 20232022
Greenwich LifeSciences logo
Greenwich LifeSciences GLSI
$ 14.01 2.49%

Greenwich LifeSciences Financial Statements 2011-2024 | GLSI

Annual Financial Statements Greenwich LifeSciences

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

183 M 170 M 256 M 330 M - - - - - - - - -

Shares

12.8 M 12.8 M 13.1 M 8.79 M - - - - - - - - -

Historical Prices

14.3 13.2 19.5 31.3 - - - - - - - - -

Net Income

-8.89 M -7.83 M -4.57 M -1.86 M -3.43 M -1.69 M - - - - - - -

Revenue

- - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - -

Operating Income

-9.33 M -8.04 M -4.6 M -1.86 M -3.43 M - - - - - - - -

Interest Expense

- - - - - - - - - - - - -

EBITDA

-9.33 M -8.04 M -4.6 M -1.86 M -3.42 M -1.69 M - - - - - - -

Operating Expenses

9.33 M 8.04 M 4.6 M 1.86 M 3.43 M 1.69 M - - - - - - -

General and Administrative Expenses

1.63 M 1.56 M 1.04 M 806 K 819 K 420 K - - - - - - -

All numbers in USD currency

Quarterly Income Statement Greenwich LifeSciences

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

12.8 M 12.8 M 12.8 M 12.8 M 12.8 M 12.8 M 13 M 13.1 M 13 M 12.9 M 12.8 M 12.7 M 8.79 M 8.59 M 8.5 M 8.46 M 292 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

-2.39 M -1.63 M -2.12 M - -2.32 M -746 K -1.97 M - -863 K -750 K -597 K - -257 K -210 K -245 K - -336 K -2.6 M -149 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-2.5 M -1.75 M -2.24 M - -2.38 M -773 K -1.99 M - -867 K -753 K -601 K - -257 K -210 K -245 K - -336 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

-2.5 M -1.75 M -2.24 M - -2.38 M -773 K -1.99 M - -867 K -753 K -601 K - -257 K -210 K -245 K - -336 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

2.5 M 1.75 M 2.24 M - 2.38 M 773 K 1.99 M - 867 K 753 K 601 K - 257 K 210 K 245 K - 336 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

345 K 368 K 413 K - 660 K 140 K 328 K - 210 K 197 K 319 K - 98.8 K 59.6 K 94.8 K - 51.5 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency